These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32361249)

  • 1. Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro-American genetic background confers optimal vaccine potential.
    Pérez I; Uranga S; Sayes F; Frigui W; Samper S; Arbués A; Aguiló N; Brosch R; Martín C; Gonzalo-Asensio J
    EBioMedicine; 2020 May; 55():102761. PubMed ID: 32361249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials.
    Arbues A; Aguilo JI; Gonzalo-Asensio J; Marinova D; Uranga S; Puentes E; Fernandez C; Parra A; Cardona PJ; Vilaplana C; Ausina V; Williams A; Clark S; Malaga W; Guilhot C; Gicquel B; Martin C
    Vaccine; 2013 Oct; 31(42):4867-73. PubMed ID: 23965219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in mice.
    Solans L; Uranga S; Aguilo N; Arnal C; Gomez AB; Monzon M; Badiola JJ; Gicquel B; Martin C
    Vaccine; 2014 Sep; 32(40):5192-7. PubMed ID: 25066740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
    Tameris M; Mearns H; Penn-Nicholson A; Gregg Y; Bilek N; Mabwe S; Geldenhuys H; Shenje J; Luabeya AKK; Murillo I; Doce J; Aguilo N; Marinova D; Puentes E; Rodríguez E; Gonzalo-Asensio J; Fritzell B; Thole J; Martin C; Scriba TJ; Hatherill M;
    Lancet Respir Med; 2019 Sep; 7(9):757-770. PubMed ID: 31416768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection.
    Dijkman K; Aguilo N; Boot C; Hofman SO; Sombroek CC; Vervenne RAW; Kocken CHM; Marinova D; Thole J; Rodríguez E; Vierboom MPM; Haanstra KG; Puentes E; Martin C; Verreck FAW
    Cell Rep Med; 2021 Jan; 2(1):100187. PubMed ID: 33521701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of pulmonary live tuberculosis vaccines against established asthma by subverting local immune environment.
    Tarancón R; Mata E; Uranga S; Gómez AB; Marinova D; Otal I; Martín C; Aguiló N
    EBioMedicine; 2021 Feb; 64():103186. PubMed ID: 33478923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
    Clark S; Lanni F; Marinova D; Rayner E; Martin C; Williams A
    J Infect Dis; 2017 Sep; 216(5):525-533. PubMed ID: 28329234
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Jia Q; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and Characterization of the Mycobacterium tuberculosis
    Hernandez-Pando R; Shin SJ; Clark S; Casonato S; Becerril-Zambrano M; Kim H; Boldrin F; Mata-Espinoza D; Provvedi R; Arbues A; Marquina-Castillo B; Cioetto Mazzabò L; Barrios-Payan J; Martin C; Cho SN; Williams A; Manganelli R
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31591165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Metabolomics between
    Díaz C; Pérez Del Palacio J; Valero-Guillén PL; Mena García P; Pérez I; Vicente F; Martín C; Genilloud O; Sánchez Pozo A; Gonzalo-Asensio J
    ACS Infect Dis; 2019 Aug; 5(8):1317-1326. PubMed ID: 31099236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studies.
    Broset E; Pardo-Seco J; Kanno AI; Aguilo N; Dacosta AI; Rivero-Calle I; Gonzalo-Asensio J; Locht C; Leite LCC; Martin C; Martinón-Torres F
    EBioMedicine; 2021 Mar; 65():103254. PubMed ID: 33711798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.
    Spertini F; Audran R; Chakour R; Karoui O; Steiner-Monard V; Thierry AC; Mayor CE; Rettby N; Jaton K; Vallotton L; Lazor-Blanchet C; Doce J; Puentes E; Marinova D; Aguilo N; Martin C
    Lancet Respir Med; 2015 Dec; 3(12):953-62. PubMed ID: 26598141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination.
    Vierboom MPM; Dijkman K; Sombroek CC; Hofman SO; Boot C; Vervenne RAW; Haanstra KG; van der Sande M; van Emst L; Domínguez-Andrés J; Moorlag SJCFM; Kocken CHM; Thole J; Rodríguez E; Puentes E; Martens JHA; van Crevel R; Netea MG; Aguilo N; Martin C; Verreck FAW
    Cell Rep Med; 2021 Jan; 2(1):100185. PubMed ID: 33521699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG.
    Martín C; Marinova D; Aguiló N; Gonzalo-Asensio J
    Vaccine; 2021 Dec; 39(50):7277-7285. PubMed ID: 34238608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic.
    Gonzalo-Asensio J; Marinova D; Martin C; Aguilo N
    Front Immunol; 2017; 8():1803. PubMed ID: 29326700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice.
    Aguilo N; Uranga S; Marinova D; Monzon M; Badiola J; Martin C
    Tuberculosis (Edinb); 2016 Jan; 96():71-4. PubMed ID: 26786657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis.
    Levillain F; Kim H; Woong Kwon K; Clark S; Cia F; Malaga W; Lanni F; Brodin P; Gicquel B; Guilhot C; Bancroft GJ; Williams A; Jae Shin S; Poquet Y; Neyrolles O
    Vaccine; 2020 Feb; 38(6):1416-1423. PubMed ID: 31862194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model.
    Cervantes-Villagrana AR; Hernández-Pando R; Biragyn A; Castañeda-Delgado J; Bodogai M; Martínez-Fierro M; Sada E; Trujillo V; Enciso-Moreno A; Rivas-Santiago B
    Vaccine; 2013 Jan; 31(4):676-84. PubMed ID: 23196205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTBVAC from discovery to clinical trials in tuberculosis-endemic countries.
    Marinova D; Gonzalo-Asensio J; Aguilo N; Martin C
    Expert Rev Vaccines; 2017 Jun; 16(6):565-576. PubMed ID: 28447476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection against Tuberculosis.
    Ahn SK; Tran V; Leung A; Ng M; Li M; Liu J
    Mol Ther; 2018 Dec; 26(12):2863-2874. PubMed ID: 30274790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.